Laurie J. Olson - Aug 15, 2022 Form 4/A - Amendment Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
10/12/2022, 05:04 PM
Date Of Original Report
Aug 16, 2022
Previous filing
Jun 16, 2022
Next filing
Oct 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1K -5.56% $0.00 17K Aug 15, 2022 Common Stock 1K $84.86 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.
F2 This Form 4/A amends the Form 4 filed by the reporting person on August 16, 2022 (the "Original Form 4"), which inadvertently reported the incorrect number of securities in column 9 of Table II. This Form 4/A is being filed solely to correct the number of securities reported in column 9 of Table II. No other amendments or changes have been made to the Original Form 4.